149 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
MRK Merck & Company, Inc. $70.42 $187.28B Buy
Article Searches
Accenture Brings Open Partner Ecosystem for Drug Discovery http://www.zacks.com/stock/news/339622/accenture-brings-open-partner-ecosystem-for-drug-discovery?cid=CS-ZC-FT-339622 Nov 27, 2018 - The ecosystem backed by cloud-based informatics research platform is likely to drive Accenture's (ACN) Products Segment.
4 Big Pharma Stocks to Add to Your Portfolio in December http://www.zacks.com/stock/news/339943/4-big-pharma-stocks-to-add-to-your-portfolio-in-december?cid=CS-ZC-FT-339943 Nov 29, 2018 - The large-cap pharma industry has been on a strong footing lately. Here are four stocks from the space that investors may consider betting on.
Dow Records Highest Single Day Gain in 8 Months: 5 Picks http://www.zacks.com/stock/news/339995/dow-records-highest-single-day-gain-in-8-months-5-picks?cid=CS-ZC-FT-339995 Nov 29, 2018 - Despite stock market mayhem, fundamentals of the U.S. economy remain strong which will help sustain the rally.
Moderna Proposes Terms For $500 Million Biotech IPO https://seekingalpha.com/article/4225400-moderna-proposes-terms-500-million-biotech-ipo?source=feed_tag_ipo_analysis Nov 29, 2018 - Moderna aims to raise $500 million in the largest development stage biotech IPO.The firm has developed an mRNA-based platform to advance an ambitious pipeline of vaccines and therapeutics for a range
Novartis' Gilenya Approved in EU for Expanded Population http://www.zacks.com/stock/news/340523/novartis-gilenya-approved-in-eu-for-expanded-population?cid=CS-ZC-FT-340523 Nov 30, 2018 - Novartis (NVS) gains the EU approval for MS drug Gilenya for children who are 10-17 years old with relapsing-remitting forms of multiple sclerosis.
Shire's Takhzyro Gets European Nod for Hereditary Angioedema http://www.zacks.com/stock/news/340828/shires-takhzyro-gets-european-nod-for-hereditary-angioedema?cid=CS-ZC-FT-340828 Dec 03, 2018 - Shire's (SHPG) gets European approval for Takhzyro subcutaneous injection, for routine prevention of recurrent attacks of hereditary angioedema (HAE) in patients aged 12 years and older.
Incyte (INCY) Announces Positive Data on Jakafi for GVHD http://www.zacks.com/stock/news/341138/incyte-incy-announces-positive-data-on-jakafi-for-gvhd?cid=CS-ZC-FT-341138 Dec 04, 2018 - Incyte (INCY) announces positive data on lead drug Jakafi at the ASH meet for the indication of acute GVHD.
Cancer Research Highlight: BeiGene Also Showed Up At ASH With Potentially Crucial Checkpoint Data https://seekingalpha.com/article/4226368-cancer-research-highlight-beigene-also-showed-ash-potentially-crucial-checkpoint-data?source=feed_sector_healthcare Dec 05, 2018 -
AbbVie Halts Rova-T Phase III Second-Line Lung Cancer Study http://www.zacks.com/stock/news/341638/abbvie-halts-rova-t-phase-iii-second-line-lung-cancer-study?cid=CS-ZC-FT-341638 Dec 06, 2018 - IDMC recommends AbbVie (ABBV) to stop enrolment in a late-stage study on its small cell lung cancer candidate, Rova-T.
Novartis Presents Additional Data on Breast Cancer Candidate http://www.zacks.com/stock/news/341919/novartis-presents-additional-data-on-breast-cancer-candidate?cid=CS-ZC-FT-341919 Dec 07, 2018 - Novartis (NVS) presents supplementary data from phase III study on BYL719 in combination with Faslodex for the treatment of advanced breast cancer. The study scripts success in PFS.

Pages: 123456...15

Page 1>

Related Companies

Name Exchange Price Mkt Cap
NVS Novartis AG NYSE $85.13 $197.65B
ABBV AbbVie Inc. NYSE $95.37 $144.42B
PFE Pfizer, Inc. NYSE $43.01 $252.13B
ABT Abbott Laboratories NYSE $67.67 $118.71B
NVO Novo Nordisk A/S NYSE $47.64 $114.84B
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for Merck & Company
MRK - Google Finance https://www.google.com/finance?q=MRK Industry related info and international coverage Summary News
MRK - Bloomberg http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=MRK Original news and commentary from Bloomberg Charts Financials with pensions Snapshot Earnings Transactions People Options